Marinus Pharmaceuticals, Inc.

MRNS · NASDAQ
Analyze with AI
$0.55+$0.00 (+0%)
At close:Feb 10, 2025, 9:00 PM UTC
$0.5498−$0.0003 (−0.05%)
After hours:Feb 11, 2025, 12:53 PM UTC
P/E TTM-0.52
P/B TTM-0.47
P/S TTM1.83
Dividend Yield0%
EPS-$2.47
Beta1.262
Valuation
PEG Ratio-0.07
FCF Yield-169.40%
EV / EBITDA-0.85
Quality
ROIC-122.85%
Gross Margin90.43%
Cash Conv. Ratio0.82
Growth
Revenue 3Y CAGR26.40%
FCF Growth-3.02%
Safety
Net Debt / EBITDA-0.26
Interest Coverage-6.30
Efficiency
Inventory Turnover0.24
Cash Conv. Cycle775.86

Marinus Pharmaceuticals, Inc. (MRNS) stock FAQs

Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.

What is Marinus Pharmaceuticals, Inc. (MRNS) stock price today?

As of Feb 10, 2025, 9:00 PM UTC, Marinus Pharmaceuticals, Inc. (MRNS) stock is trading at $0.55. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date MRNS stock quotes for informed trading decisions.

What is Marinus Pharmaceuticals, Inc.'s market capitalization?

Marinus Pharmaceuticals, Inc. (MRNS) has a market capitalization of approximately $30.4M. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare Marinus Pharmaceuticals, Inc.'s size relative to other companies in the USD market. The market cap figure updates automatically as the MRNS stock price changes.

What is the 52-week range for Marinus Pharmaceuticals, Inc. stock?

Marinus Pharmaceuticals, Inc. (MRNS) stock has traded in a 52-week range of $0.22 — $10.50. The 52-week range shows the highest and lowest prices at which MRNS traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current Marinus Pharmaceuticals, Inc. stock price to this range provides context for recent price action.

How much trading volume does Marinus Pharmaceuticals, Inc. stock have?

Marinus Pharmaceuticals, Inc. (MRNS) stock recently traded approximately 1.1M shares. Trading volume indicates market liquidity and investor interest in MRNS. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting Marinus Pharmaceuticals, Inc. stock.

Does Marinus Pharmaceuticals, Inc. pay dividends to shareholders?

Yes, Marinus Pharmaceuticals, Inc. (MRNS) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate Marinus Pharmaceuticals, Inc. stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is Marinus Pharmaceuticals, Inc.'s intraday price range?

Today, Marinus Pharmaceuticals, Inc. (MRNS) stock has traded in a range of $0.5492 — $0.55. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring MRNS's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get Marinus Pharmaceuticals, Inc. stock data?

AlphaPilot sources real-time MRNS stock quotes, fundamental financial data, and historical price charts for Marinus Pharmaceuticals, Inc. from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The Marinus Pharmaceuticals, Inc. stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of MRNS stock performance.